|
Q4 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Mar 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | ||||||||
| Restricted cash | ||||||||
| Accounts receivable, net | ||||||||
| Inventories, net | ||||||||
| Advance to suppliers | ||||||||
| Due from related parties | ||||||||
| Related Party | ||||||||
| Total due from related parties | ||||||||
| Other receivables and other current assets, net | ||||||||
| Total Current Assets | ||||||||
| Non-current Assets | ||||||||
| Property, plant and equipment, net | ||||||||
| Intangible assets, net | ||||||||
| Long-term deposit | ||||||||
| Right-of-use assets – operating leases – related party | ||||||||
| Related Party | ||||||||
| Total right-of-use assets – operating leases – related party | ||||||||
| Total Non-current Assets | ||||||||
| TOTAL ASSETS | ||||||||
| Liabilities and Equity | ||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
| Current Liabilities | ||||||||
| Short-term borrowings | ||||||||
| Long-term borrowings – current portion | ||||||||
| Short-term convertible notes | ||||||||
| Accounts payable | ||||||||
| Refund liabilities | ||||||||
| Contract liabilities | ||||||||
| Amounts due to related parties | ||||||||
| Related Party | ||||||||
| Accrued expenses and other liabilities | ||||||||
| Tax payable | ||||||||
| Operating lease liabilities – current – related party | ||||||||
| Related Party | ||||||||
| Total Current Liabilities | ||||||||
| Bank loans – non-current portion | ||||||||
| Non-current Liabilities | ||||||||
| Long-term borrowings – non current portion | ||||||||
| Operating lease liabilities – non-current – related party | ||||||||
| Related Party | ||||||||
| Total Non-current Liabilities | ||||||||
| TOTAL LIABILITIES | ||||||||
| SHAREHOLDERS’ EQUITY | ||||||||
| Ordinary shares, unlimited shares authorized, no par value, 958,077 class A ordinary shares issued and outstanding 4 class B ordinary shares issued as of March 31, 2026 (91,756 shares issued and outstanding as of March 31, 2025) | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficits | ||||||||
| Accumulated other comprehensive loss | ||||||||
| Total Shareholders’ Equity | ||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Loading...
